Asymptomatic Severe Aortic Stenosis, When Should We Intervene?

Data from recent observational randomized studies suggest that most patients with asymptomatic severe aortic stenosis will eventually receive an indication for valve replacement.

Infarto agudo de miocardio y lesiones de múltiples niveles

 

Mortality in this “asymptomatic” population is caused not only by sudden death, but also by cardiac death. Early intervention may prevent these deaths as a consequence of aortic stenosis symptoms.

Researchers conducted a meta-analysis to learn about the natural contemporary history of asymptomatic severe aortic stenosis. Their main concern was all-cause death occurring during conservative treatment.

Cardiac death, death due to heart failure, sudden death, symptom onset, indication for aortic valve replacement, and aortic valve replacement were also assessed.

The primary endpoint of this study was comparing long-term mortality among patients receiving early intervention vs. those receiving conservative treatment (intervention only after symptom onset).


Read also: Intervention in Congenital Heart Disease.


A total of 4075 patients from 29 studies were analyzed.

Early intervention was associated with a significant reduction in long-term mortality (hazard ratio: 0.38; 95% confidence interval, 0.25-0.58).

Factors associated with worse prognosis in asymptomatic patients were severity of stenosis, low-flow, ventricular damage, and concomitant atherosclerotic disease.

Conclusion

Data from observational randomized studies suggest that the onset of symptoms in aortic stenosis may be cardiac death (such as heart failure), and not only sudden death. Other endpoints besides sudden death should be considered during the decision to perform early valve intervention.

jamacardiology_gahl_2020_oi_200043_1602688141-17564free

Original Title: Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes A Systematic Review and Meta-analysis.

Reference: Brigitta Gahl et al. JAMA Cardiol. 2020;5(10):1102-1112. doi:10.1001/jamacardio.2020.2497.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...